Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
3(38%)

Phase Distribution

Ph not_applicable
7
88%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

37.5%

3 of 8 finished

Non-Completion Rate

62.5%

5 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(3)
Terminated(5)

Detailed Status

Completed3
Terminated3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (12.5%)
N/A7 (87.5%)

Trials by Status

completed338%
terminated338%
withdrawn225%

Recent Activity

0 active trials
Showing 5 of 8
terminatednot_applicable

Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus

NCT03560609
withdrawnphase_2

Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure

NCT00406731
withdrawnnot_applicable

Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy Humans

NCT00275756
terminatednot_applicable

Choroidal Thickness During Changes in Intraocular Pressure and Arterial Blood Pressure

NCT01333891
terminatednot_applicable

Role of Nitric Oxide in Optic Nerve Head Blood Flow Regulation During Experimental Increase of Intraocular Pressure in Healthy Humans

NCT00914394
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03560609Not Applicable

Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus

Terminated
NCT00406731Phase 2

Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure

Withdrawn
NCT00275756Not Applicable

Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy Humans

Withdrawn
NCT01333891Not Applicable

Choroidal Thickness During Changes in Intraocular Pressure and Arterial Blood Pressure

Terminated
NCT00914394Not Applicable

Role of Nitric Oxide in Optic Nerve Head Blood Flow Regulation During Experimental Increase of Intraocular Pressure in Healthy Humans

Terminated
NCT00806741Not Applicable

Role of Nitric Oxide in Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Healthy Humans

Completed
NCT00915070Not Applicable

Role of Endothelin-1 in Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Healthy Humans

Completed
NCT00912665Not Applicable

Regulation of Optic Nerve Head Blood Flow During Combined Changes in Intraocular Pressure and Arterial Blood Pressure

Completed

All 8 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
8